About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Retirement of Non-Executive Director

May 19, 2016

Click here to read more

Post navigation

Phosphagenics Expands License Agreement for Diclofenac Gel

2016 May 19 AGM Chairman and CEO Addresses

Related Posts

Quarterly Activities Report and 4C – to 31 March 2023

April 28, 2023May 20, 2023

Athenex takes Avecho’s Vitamin K injection to FDA pre-IND meeting

January 12, 2023January 12, 2023

Equity Capital Raising Placement of New Shares

September 1, 2014

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.